Genetics 5-Prenatal Diagnosis of Genetic Diseases Flashcards
What is the nuchal scan
Done at 12 weeks Uses of the Nuchal Scan: Date the pregnancy Multiple Pregnancies Major Foetal Abnormalities Early Miscarriage Assess risks of Down Syndrome and other chromosomal abnormalities
Nuchal Translucency (NT)
10-14 weeks
Measure of the fluid at the back of the baby’s neck.
NT is usually below 3.5mm
Increased >3mm can indicate:
Chromosome Abnormalities - e.g. Down’s, Patau, Turner, Edwards NT + maternal age detects up to 75% of Down Syndrome - 5% false positive rate (combined test)
Birth Defects:
Cardiac Anomalies
Pulmonary Defects (e.g. diaphragmatic hernia)
Renal Defects
Abdominal Wall Defects (e.g. omphalocele)
Skeletal Dysplasia
When is prenatal testing arranged?
Following abnormal findings at nuchal or mid-trimester scan.
Following results of combined test which give an increased risk of Down Syndrome.
If previous pregnancy affected with a condition e.g. Down Syndrome, Cystic Fibrosis
If the parent(s) is a carrier of chromosome rearrangement or genetic condition e.g. Duchenne Muscular Dystrophy, Huntingdon’s Disease
Family History of genetic condition
Aims of Prenatal Testing
To inform and prepare parents for the birth of an effected child.
In utero treatment could be offered.
Aids management of the rest of the pregnancy
Allows parents to prepare for complications at or after birth.
To allow TERMINATION of an affected foetus.
What types of prenatal tests
non invasive:
Ultrasound/mri
Minimally invasive:
Maternal blood test
Cell-free foetal dna
Invasive:
Chorionic Villus Sampling (CVS)
Amniocentesis
What are the uses of non invasive scans?
Ultrasound
Early/dating scan (can be done from 5 weeks but best from 9 weeks)
Nuchal Translucency and nasal bone
High level/anomaly scan
Foetal MRI
20+ weeks
High level and anomaly scan can be diagnostic - showing cleft lip, limb deformity or cardiac problem.
It can also show soft markers for other problems.
Nasal Bone - soft marker - presence or absence can indicate Down Syndrome.
When taken alongside NT and maternal age, looking at the Nasal Bone increases the sensitivity of DS screening.
Foetal Cardiac Scans can show cardiac problems - only done if the other scans indicate potential problem.
Uses of minimally invasive prenatal tests
Types of Maternal Serum Screening:
1st Trimester - 11-14 weeks - done alongside the NT measurement (looks for the presence of hCG (human chorionic gonadotrophin) and PAPP A (pregnancy associated plasma protein A)).
2nd Trimester - 16-20 weeks - done if they are booked in later in pregnancy - looks for hCG and PAPP A and AFP (alpha foetal protein) and uE3 (oestriol).
What is cell free feotal dna testing
OFFERED PARTICULARLY IF THE BABY HAS A CHANCE OF HAVING AN X-LINKED CONDITION.
So only boys can be affected and girls can be carriers.
This testing is done to determine the sex of the baby.
A small amount of Foetal DNA will be in the maternal blood.
A blood test can be done to isolate that DNA and to look for the presence of the Y chromosome.
If the Y chromosome is present, you know the baby is male.
cffDNA is first detectable from 4-5 weeks but is more accurately detected around 9 weeks.
Uses of cffDNA Testing
Offered primarily when there is a sex-linked condition in the family to sex the pregnancy e.g. DMD
Blood Test - 9 weeks
Test detects SRY gene (sex-determining region Y) on the Y chromosome - determines whether the foetus is male or female.
Describe Chorionic Villus Sampling (CVS)
11-14 weeks
1-2% Risk of Miscarriage
Transabdominal or Transvaginal
Chorionic Villus - part of the developing placenta - has the same DNA as the foetus
Gives an earlier result than amniocentesis - important for patients deciding on termination of pregnancy
Describe Amniocentesis
16+ weeks
Takes sample of amniotic fluid which contains foetal cells
Up to 1% risk of miscarriage
Performed later than CVS
Performed by sticking a needle through the abdomen
What type of test is done with the DNA sample from CVS or Amniocentesis?
Karyotype - done if there is a chromosomal abnormality in the family. E.g. if the parents are carriers of a balanced translocation.
Results in 2 weeks (dependent upon the cells growing)
QF-PCR (Quantitative Fluorescence PCR)
All prenatal samples have a QF-PCR test
Test for T13, T18 and T21 (and sex chromosomes if sex chromosome disorder is suspected)
Results: 24-48 hours
If there is a known reproductive risk what are the options
Conceive naturally - no prenatal testing
Conceive naturally - have prenatal testing
Egg and/or Sperm Donors
Adoption
Choose not to have children
Pre-implantaion Genetic Diagnosis (PGD)
What is the process for preimplantation genetic diagnosis
Stimulation of the ovaries - stimulate the ovaries to produce more eggs
Eggs are collected
Insemination - either by IVF (sperm and egg placed together in a culture dish) or ICSI (Intra-Cytoplasmic Sperm Injection - injection of a single sperm into each egg).
Fertilisation
Embryo Biopsy - once embryo gets to about 8 cells in size, a cell is removed by embryo biopsy.
Embryo Testing
Embryo Transfer - embryos that don’t have the genetic condition or are carriers are considered for embryo transfer (maximum 2 are transferred)
Pregnancy Test
What is the Eligibility Criteria for PGD
Female partner is under 40
Female partner has BMI between 19 and 30
Both partners are non-smokers
No living unaffected children from the relationship
Known risk of having a child affected by a serious genetic condition
A licence is required from the HFEA for each genetic condition or indication
Eligible couples are usually funded for three rounds of PGD